Protalix BioTherapeutics, Inc. (DE) (PLX): Price and Financial Metrics

PLX POWR Grades

• PLX scores best on the Value dimension, with a Value rank ahead of 79.7% of US stocks.
• The strongest trend for PLX is in Stability, which has been heading down over the past 52 weeks.
• PLX ranks lowest in Stability; there it ranks in the 5th percentile.

PLX Stock Summary

• Protalix BioTherapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.98% of US listed stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -42.74 for Protalix BioTherapeutics Inc; that's greater than it is for merely 0.59% of US stocks.
• The volatility of Protalix BioTherapeutics Inc's share price is greater than that of 99.23% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to PLX, based on their financial statements, market capitalization, and price volatility, are WMG, CAH, IEA, SEAS, and STCN.
• PLX's SEC filings can be seen here. And to visit Protalix BioTherapeutics Inc's official web site, go to www.protalix.com.

PLX Valuation Summary

• In comparison to the median Healthcare stock, PLX's price/sales ratio is 85.9% lower, now standing at 1.6.
• Over the past 243 months, PLX's price/sales ratio has gone NA NA.
• Over the past 243 months, PLX's EV/EBIT ratio has gone down 7.8.

Below are key valuation metrics over time for PLX.

PLX Growth Metrics

• Its 2 year price growth rate is now at -14%.
• Its 2 year cash and equivalents growth rate is now at -65.72%.
• The 4 year revenue growth rate now stands at 122137.04%.

PLX's revenue has moved up $44,932,000 over the prior 70 months.

The table below shows PLX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	49.296	-12.748	-20.518
2021-06-30	48.032	-14.472	-20.756
2021-03-31	52.572	-28.823	-13.665
2020-12-31	62.898	-26.106	-6.523
2020-09-30	61.162	-22.243	-6.629
2020-06-30	64.62	-21.864	-5.752

PLX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PLX has a Quality Grade of C, ranking ahead of 73.31% of graded US stocks.
• PLX's asset turnover comes in at 0.547 -- ranking 71st of 681 Pharmaceutical Products stocks.
• MNKD, XTNT, and NBIX are the stocks whose asset turnover ratios are most correlated with PLX.

The table below shows PLX's key quality metrics over time.